Review of dendritic cell vaccine in the treatment of hepatocellular carcinoma
10.3760/cma.j.issn.1007-8118.2017.12.018
- VernacularTitle:树突状细胞疫苗治疗肝细胞癌的研究进展
- Author:
Weichao DOU
1
;
Peng CHEN
;
Ming HUANG
;
Feng LIU
;
Min HE
;
Mingdao HU
Author Information
1. 650000,昆明医科大学第二附属医院肝胆胰外科
- Keywords:
Hepatocellular carcinoma (HCC);
Dendritic cell vaccine;
Immunotherapy
- From:
Chinese Journal of Hepatobiliary Surgery
2017;23(12):853-857
- CountryChina
- Language:Chinese
-
Abstract:
Hepatocellular carcinoma (HCC) is the most common malignant tumor of liver.HCC is characterized with poor early detection rate and rapid progression.Therefore,bringing the patients with heavy burden of disease,though poor prognosis.Conventional treatment options can include surgical resection or liver transplantation,trans-arterial chemoembolization,ablation,and targeted therapy,but it remains unsatisfying in prognosis improvement.By years,we have come to realize the role of dendritic cells in tumor immunotherapy.Dendritic cells will become a promising treatment option in improvement of prognosis of HCC patients.In this review,we will focus on current trends and updates on dendritic cell vaccines in HCC treatment.
